HBV genotype is associated with early (week 12) virologic response during TDF or TAF therapy in patients with chronic hepatitis B

臺大醫院;臺大醫院-醫學研究部;臺大醫學院-臨床醫學研究所;Acharya, Subrat K.Subrat K.AcharyaLee, Kwan SikKwan SikLeeKao, Jia-HorngJia-HorngKaoFlisiak, RobertRobertFlisiakFlaherty, John F.John F.FlahertyKim, KyungpilKyungpilKimLin, LanjiaLanjiaLinGaggar, AnujAnujGaggarMyers, Robert P.Robert P.MyersOsipenko, MarinaMarinaOsipenkoPianko, StephenStephenPiankoChow, Wan-ChengWan-ChengChowPan, Calvin Q.Calvin Q.Pan2017-06-222018-07-062017-06-222018-07-062016http://ntur.lib.ntu.edu.tw//handle/246246/279920[SDGs]SDG3HBV genotype is associated with early (week 12) virologic response during TDF or TAF therapy in patients with chronic hepatitis B